COVID-19 treatment guidelines in adults
DOI:
https://doi.org/10.24265/horizmed.2021.v21n1.11Keywords:
Coronavirus infections, Treatment, Drug administration schedule, Adult respiratory distress syndrome, Severe acute respiratory syndrome, Pneumonia, Sepsis, Septic shockAbstract
A novel coronavirus disease called COVID-19 was discovered as a result of the outbreak that began in China at the end of December 2019. Common symptoms are fever, dry cough, shortness of breath and malaise. Several research are being conducted since the disease has high transmission rate even though it is not considered life-threatening. However, together with hospital and out-of-hospital care, there is a group of medications being used to fight this disease, such as hydroxychloroquine, chloroquine, remdesivir, lopinavir/ritonavir, tocilizumab, interferon beta-1b, among others.
Downloads
References
World Health Organization. Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19) [Internet]. 2019. Disponible en: https://www.who.int/es/emergencies/diseases/novelcoronavirus-2019/advice-for-public/q-a-coronaviruses
Ministerio Nacional de Salud. ABECÉ: Nuevo coronavirus (COVID-19) de China [Internet]. Colombia: Minsalud. 2020. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/ RIDE/VS/PP/ET/abece-coronavirus.pdf
Pan American Health Organization. Evento: COVID-19. Novel coronavirus 2019 [Internet]. 2020. Disponible en: https://www.paho.org/arg/index.php?option=com_ docman&view=download&alias=433-covid-19-presentacion-opsarg20200212&category_slug=2019-ncov-1&Itemid=624
Departament de Salut. Tratamiento antiviral e inmunomodulador de la infección por SARS-Cov-2. Valencia: La Fe; 2020.
UpToDate. Predictive scoring systems in the intensive care unit [Internet]. 2018-2020. Disponible en: https://www. uptodate.com/contents/predictive-scoring-systems-in-theintensive-care-unit?search=score%20sofa&source=search_ result&selectedTitle=1~20&usage_type=default&display_ rank=1#H889841588
UpToDate. Coronavirus disease 2019 (COVID-19) [Internet]. 2020. Disponible en: https://www.uptodate.com/contents/coronavirusdisease-2019-covid-19?search=coronavirus&source=search_re sult&selectedTitle=1~150&usage_type=default&display_ rank=1#H2133052422
Van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, et al. Aerosol and surface stability of HCoV-19 (SARSCoV-2) compared to SARS-CoV-1. N Engl J Med. 2020.
Nebraska Medicine. COVID-19 Antiviral and Pharmacotherapy information [Internet]. 2020. Disponible en: https://www. nebraskamed.com/sites/default/files/documents/covid-19/ antiviral-and-pharmacotherapy-information.pdf
Kunz R, Minder M. COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes. Swiss Med Wkly. 2020; 150: w20235.
UpToDate. Acetaminophen (paracetamol): drug information [Internet]. 2020. Disponible en: https://www.uptodate.com/ contents/acetaminophen-paracetamol-drug-information?search=par acetamol&topicRef=340&source=see_link#F129370
Michigan Medicine. Outpatient guidance for treatment of Covid-19 in adults and children [Internet]. 2020. Disponible en: http://www. med.umich.edu/asp/pdf/outpatient_guidelines/COVID-19-ambtreatment.pdf
University of Washington - Medicine COVID-19 Resource Site. Washington: UW Medicine Interim Treatment Guidelines for SARSCoV-2 Infection/COVID-19 [Internet]. 2020. Disponible en: https:// covid-19.uwmedicine.org/Pages/default.aspx
Centers for Disease Control and Prevention. Coronavirus Disease 2019 (Covid-19): Information for clinicians on therapeutic options for patients with Covid-19 [Internet]. 2020. Disponible en: https:// www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html
UpToDate. Azithromycin (systemic) Drug information [Internet]. 1978-2020. Disponible en: https://www.uptodate.com/contents/ azithromycin-systemic-drug-information?search=Azithromycin&topi cRef=9041&source=see_link
Sandro G, Wilson C. Clinical trials on drug repositioning for COVID-19 treatment [Internet]. 2020; 44(40). Disponible en: https://www. paho.org/journal/sites/default/files/2020-03/40-20-249-Rosaprelim.pdf
UpToDate. Lopinavir and ritonavir: drug information [Internet]. 1978-2020. Disponible en: https://www.uptodate.com/contents/ lopinavir-and-ritonavir-drug-information?search=lopinavir&source =search_result&selectedTitle=1~64&usage_type=default&display_ rank=1#F189743
Pan American Health Organization. Guía para el cuidado crítico de pacientes adultos graves con coronavirus (covid-19) en las Américas [Internet]. 2020. Disponible en: https://www.paho.org/col/index. php?option=com_docman&view=download&alias=2295-guias-covid19-cuidado-critico-abril-2020-abril-version-larga-v1&category_ slug=covid-19&Itemid=688
Virginia Z. COVID-19 Referencia de bolsillo para médicos institucionales [Disertación]. Colombia: Fundación Valle del LILI. 2020.
Vademecum. Interferón beta-1b [Internet]. 2015-202. Disponible en: https://www.vademecum.es/principios-activos-interferon+beta-1bl03ab08
UpToDate. Interferón beta-1b: Drug information [Internet]. 1978- 2020. Disponible en: https://www.uptodate.com/contents/ interferon-beta-1b-drug-information?search=Interferon%20beta%20 1b&source=panel_search_result&selectedTitle=1~10&usage_ type=panel&kp_tab=drug_general&display_rank=1
Johnson M, Badulak R. Emergency department COVID-19 airway policies [Dissertación]. University of Washington: Department of Emergency Medicine. 2020.
Agencia española de medicamentos y productos sanitarios. Tratamientos disponibles para el manejo de la infección respiratoria pro SARS-Cov-2 [Internet]. Disponible en: https://www.aemps. gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-delcovid%e2%80%9119/tratamientos-disponibles-para-el-manejo-de-lainfeccion-respiratoria-por-sars-cov-2/?lang=en
Ministerio de Salud. Documento Técnico: Atención y manejo clínico de casos de Covid-19 [Internet]. Perú; 2020. Disponible en: https:// cdn.www.gob.pe/uploads/document/file/545934/07_03_FINAL_ BCM_DOCUMENTO_TE%CC%81CNICO__002_.pdf
Ministerio de Sanidad, Consumo y Bienestar Social de España. Documento técnico. Manejo clínico del COVID-19: atención hospitalaria [Internet]. 2020. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/ nCovChina/documentos/Protocolo_manejo_clinico_ah_COVID-19.pdf
UpToDate. Coronavirus disease 2019 (COVID-19): Critical care issues [Internet]. 2020. Disponible en: https://www.uptodate. com/contents/coronavirus-disease-2019-covid-19-critical-careissues?search=sepsis%20covid19&source=search_result&selectedTitl e=1~150&usage_type=default&display_rank=1#H369339320
Francisco A, Orlando D. Neumonía grave del adulto adquirido en la comunidad. Rev Chil Enferm Respir. 2005; 21(2): 111-6.
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDAapproved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020; 178: 104787.
Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19 [Internet]. 2020. Disponible en: https://www.fda.gov/ news-events/press-announcements/coronavirus-covid-19-updatefda-coordinates-national-effort-develop-blood-related-therapiescovid-19
Morris J, Badulak W. Pharmacologic adjuncts for critical illness in suspected COVID-19. Harborview Medical Center: EM COVID-19 Critical Illness Working Group. University of Washington: Department of Emergency Medicine. 2020.
UpToDate. Evaluation and management of suspected sepsis and septic shock in adults [Internet]. 2020. Disponible en: https:// www.uptodate.com/contents/evaluation-and-management-ofsuspected-sepsis-and-septic-shock-in-adults?search=sepsis%20 treatment&source=search_result&selectedTitle=1~150&usage_ type=default&display_rank=1#H4
Clinical Overview. Coronavirus: novel coronavirus (COVID – 19) Infection [Internet]. ClinicalKey: Elseiver. 2020. Disponible en: https://www.clinicalkey.com/#!/content/clinical_overview/67- s2.0-0e7112a3-e94d-4136-94ba-cfdf9242ea43
Mirón Rubio M, Estrada Cuxart O, González Ramallo VJ. Protocolo tratamiento antimicrobiano domiciliario endovenoso (TADE) [Internet]. 2020. Disponible en: https://www.fesemi.org/sites/ default/files/documentos/publicaciones/capitulo-11.pdf
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
